期刊文献+

脾脏酪氨酸激酶促进肝肺综合征大鼠肺血管新生 被引量:2

Splenic tyrosine kinase promotes pulmonary angiogenesis in rats with hepatopulmonary syndrome
原文传递
导出
摘要 本研究旨在研究脾脏酪氨酸激酶(spleen tyrosine kinase,Syk)在肝肺综合征(hepatopulmonary syndrome,HPS)血管新生过程中的作用及其机制。Sprague Dawley(SD)大鼠随机分为3组:假手术组(Sham组)、胆总管结扎(common bile duct ligation,CBDL)5周组(5W组)和R788药物干预组(R788组),通过CBDL术进行HPS造模,R788组大鼠在CBDL术后每日腹腔注射1次R788(20 mg/kg)至第5周。用Western blot和免疫组织化学法检测Syk、p-Erk1/2、p-Akt在肺组织中的表达和分布情况,用免疫荧光染色法观察Syk在肺中的定位和肺组织血管新生数目。结果显示,相对Sham组,5W组大鼠Syk蛋白表达水平显著上调,Erk1/2和Akt磷酸化水平显著上调,肺微血管数量显著增加;相对5W组,R788组大鼠Syk蛋白表达水平显著下调,Erk1/2和Akt磷酸化水平显著下调,肺微血管数量显著减少。以上结果表明,Syk可能通过激活下游Erk1/2和Akt信号转导通路促进HPS模型大鼠肺内血管新生,这为HPS的临床治疗提供了理论依据和潜在药物治疗靶点。 The present paper was aimed to study the role of spleen tyrosine kinase(Syk)in angiogenesis in hepatopulmonary syndrome(HPS)and the underlying mechanism.Sprague Dawley(SD)rats were randomly divided into three groups:sham operation group(sham group),common bile duct ligation(CBDL)5-week group(5 W group)and R788 intervention group(R788 group).HPS model was established by CBDL.Rats in R788 group were intraperitoneally injected with R788(20 mg/kg)once daily to week 5 after CBDL operation.The protein expression levels and distribution of Syk,p-Erk1/2,and p-Akt in lung tissue were detected by Western blot and immunohistochemistry.Immunofluorescence staining was used to observe the location of Syk expression and the number of angiogenesis in lung tissue.The results showed that,compared with sham group,5 W group exhibited up-regulated protein expression level of Syk,increased phosphorylation levels of Erk1/2 and Akt,and increased number of pulmonary microvessels.Compared with 5 W group,R788 group exhibited down-regulated protein expression level of Syk,decreased phosphorylation levels of Erk1/2 and Akt,and decreased number of pulmonary microvessels.These results suggest that Syk may promote pulmonary angiogenesis in HPS model rats by activating downstream Erk1/2 and Akt signaling pathways,which provides a theoretical basis and potential drug therapeutic targets for the clinical treatment of HPS.
作者 高伟忠 杨义辉 但伶 朱稀雯 GAO Wei-Zhong;YANG Yi-Hui;DAN Ling;ZHU Xi-Wen(Department of Anesthesiology,the First People’s Hospital of Zunyi,Zunyi 563000,China;Department of Anesthesiology,Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
出处 《生理学报》 CAS CSCD 北大核心 2020年第6期785-792,共8页 Acta Physiologica Sinica
基金 supported by the National Natural Science Foundation of China(No.81601715)。
关键词 脾脏酪氨酸激酶 肝肺综合征 血管新生 ERK1/2 AKT spleen tyrosine kinase hepatopulmonary syndrome angiogenesis Erk1/2 Akt
  • 相关文献

参考文献2

二级参考文献4

共引文献40

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部